Formidable Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Formidable Asset Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-43,625	Closed	-$737K	–	541
2014 Q4	$737K	Hold	43,625	–	–	0.5%	45
2014 Q3	$578K	Sell	43,625 -1,300	-3%	-$15.5K	0.38%	60
2014 Q2	$572K	Sell	44,925 -1,400	-3%	-$14.6K	0.35%	71
2014 Q1	$434K	Buy	46,325 +900	+2%	+$12.1K	0.3%	69
2013 Q4	$552K	Sell	45,425 -29,150	-39%	-$412K	0.37%	67
2013 Q3	$1.28M	Buy	+74,575	New	+$1.43M	1.1%	19

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Formidable Asset Management's INFI Position: Q1 2015 in Review

Formidable Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 43,625 shares — an estimated $737K sold.

Formidable Asset Management first reported a position in INFI in Q3 2013 and held it in 6 quarters. The position peaked at $1.28M in Q3 2013. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

Formidable Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Formidable Asset Management sold 43,625 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $737K.
Formidable Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
Formidable Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $1.28M in Q3 2013.
141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on Formidable Asset Management's 13F filing for Q1 2015, filed 14 May 2015.